Liquid Biopsies Predict Effectiveness of Hormone Treatments for mCRPC
Liquid biopsies can help identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are unlikely to benefit from anti-androgen therapies, providing clarity for physicians and...
physicians.dukehealth.org